Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 13/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.37 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4434673 | 0.82 | P2RX7 (0.42) | P2RX7S1PR1 | |
| SCHEMBL14033926 | 0.79 | P2RX7 (0.44) | BRD4P2RX7MEN1KMT2ATRPV4 | |
| SCHEMBL14033441 | 0.74 | SMN1; SMN2 (0.49) | BRD4P2RX7TRPV4 | |
| SCHEMBL29713700 | 0.72 | BRD4 (0.47) | BRD4P2RX7TRPV4TRPV3 | |
| SCHEMBL485441 | 0.72 | TRPV4 (0.48) | BRD4P2RX7TRPV4TRPV3 | |
| SCHEMBL27823408 | 0.72 | TRPV4 (0.48) | BRD4P2RX7TRPV4TRPV3 | |
| SCHEMBL30003924 | 0.72 | TRPV4 (0.48) | BRD4P2RX7TRPV4TRPV3 | |
| SCHEMBL24400563 | 0.71 | P2RX7 (0.41) | BRD4P2RX7S1PR1TRPV4 | |
| SCHEMBL4433866 | 0.71 | P2RX7 (0.42) | P2RX7PTGS1PTGS2 | |
| SCHEMBL28999639 | 0.71 | CNR2 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1423381-B1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | SCHERING CORP (US) | 2007-01-03 | — | — | EP | disclosed |